Cinacalcet reduces serum calcium concentrations in patients with intractable primary hyperparathyroidism
about
Bone turnover markers in primary hyperparathyroidism.Contemporary Medical Management of Primary Hyperparathyroidism: A Systematic Review.Cinacalcet treatment of primary hyperparathyroidismCinacalcet to prevent parathyrotoxic crises in hypercalcaemic patients awaiting parathyroidectomy.Alendronate therapy in men with primary hyperparathyroidism.Diagnosis, treatment, and follow-up of medullary thyroid carcinoma: recommendations by the Thyroid Department of the Brazilian Society of Endocrinology and Metabolism.Cinacalcet HCl reduces hypercalcemia in primary hyperparathyroidism across a wide spectrum of disease severityDeclining Rates of Inpatient Parathyroidectomy for Primary Hyperparathyroidism in the US.Bone disease in primary hyperparathyrodism.New perspectives in the management of primary hyperparathyroidismExperience with cinacalcet in primary hyperparathyroidism: results after 1 year of treatment.Cinacalcet monotherapy in neonatal severe hyperparathyroidism: a case study and review.Clinical utilization of cinacalcet in hypercalcemic conditions.Cinacalcet as alternative treatment for primary hyperparathyroidism: achievements and prospects.Behind the curtain: cellular mechanisms for allosteric modulation of calcium-sensing receptors.Diseases of the parathyroid gland in chronic kidney disease.Nonsurgical management of mild primary hyperparathyroidism - a reasonable option.Endocrine and metabolic emergencies: hypercalcaemia.Cinacalcet hydrochloride for the treatment of hyperparathyroidism.An Interesting Case of Life-Threatening Hypercalcemia Secondary to Atypical Parathyroid Adenoma versus Parathyroid Carcinoma.Surgical management of primary hyperparathyroidism in older adults.Management of hyperparathyroidism (PHP) in MEN2 syndromes in Europe.SOCIETY FOR ENDOCRINOLOGY ENDOCRINE EMERGENCY GUIDANCE: Emergency management of acute hypercalcaemia in adult patients.(18)F-Fluorocholine PET-CT enables minimal invasive parathyroidectomy in patients with negative sestamibi SPECT-CT and ultrasound: A case report.When would I use medical therapies for the treatment of primary hyperparathyroidism?Cinacalcet in the management of primary hyperparathyroidism: post marketing experience of an Italian multicentre group.Cinacalcet normalizes serum calcium in a double-blind randomized, placebo-controlled study in patients with primary hyperparathyroidism with contraindications to surgery.Cinacalcet hydrochloride relieves hypercalcemia in Japanese patients with parathyroid cancer and intractable primary hyperparathyroidism.A step towards cinacalcet testing for the diagnosis of primary hyperparathyroidism: comparison with the standardized intravenous calcium loading. A pilot study.
P2860
Q27692682-25A61F58-CB05-40A3-AE29-F9D4FFDB3337Q33580833-83437123-25EC-4585-930A-E744C923CCBAQ34725416-8C07181C-8D7A-4B3D-A18D-7218CE204490Q34964011-97320338-2D8F-4BD9-8F18-0A2B6DF692E7Q35170300-04E36C5C-E08B-432B-963F-C967ED925D8DQ35396089-11FEC25A-6089-4D38-A9B8-4F8249AC336EQ35468992-513E87BB-0B4D-4358-8EBE-15AC5F60C40FQ36105020-6856C97F-BED8-4A46-A10E-824388F1745FQ36280845-51D088AB-4F7E-4BD6-8E20-4D8B04D41C59Q36327984-BE015AA1-B133-4A05-AFAF-E1CE917A6127Q36883330-35F4C4F1-3F4E-4919-83BB-683F1EE585D7Q37428995-13FC4B7B-C110-4295-B59A-F65AFB1B63BBQ37848439-D4C87B16-F32A-46E5-962B-57AB1BAA810EQ37858461-AFD3DE8E-6AE7-4F4A-8836-AE581B5A5E0EQ37862353-EF075519-F03E-4011-89A3-134DF076030DQ37912038-6E6C862C-32E4-4287-B0C5-4B0B62BFC19AQ38026863-CCEF25AD-BB00-451F-BDC4-F67A0B21EA4CQ38059483-A2F1DEF6-E0A0-4AFE-B99B-3D5BBCBA5BE8Q38085702-1C8D3197-228B-4F9F-AA11-1FAC70AFAAEEQ38222752-EC645F8D-7C0F-4843-BBCE-2ADEFFD433A4Q38239070-AD62E23E-43B8-44E2-84BB-3A1D9948E971Q41043742-2CD3AD40-5190-47B3-BE63-A0B115AA0DE3Q42320852-EB48D935-BDE3-4492-AB78-8F8BD4D535E8Q42427554-216D730B-F776-4AF3-906D-1BAF0123EA77Q43662645-EB2645F4-0EB6-477F-8F8A-BAC844CAE473Q45859429-B181E106-D252-444C-8FDD-79D5977FC20BQ46369997-57E3F4AF-F4FE-475B-8306-935AD1B82A8EQ50223055-58095B52-F60B-4F33-B7C0-715E8074F8F4Q53621299-425481A8-7DC0-49BD-94C8-11F6C71AB6BA
P2860
Cinacalcet reduces serum calcium concentrations in patients with intractable primary hyperparathyroidism
description
2009 nî lūn-bûn
@nan
2009 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Cinacalcet reduces serum calci ...... le primary hyperparathyroidism
@ast
Cinacalcet reduces serum calci ...... le primary hyperparathyroidism
@en
type
label
Cinacalcet reduces serum calci ...... le primary hyperparathyroidism
@ast
Cinacalcet reduces serum calci ...... le primary hyperparathyroidism
@en
prefLabel
Cinacalcet reduces serum calci ...... le primary hyperparathyroidism
@ast
Cinacalcet reduces serum calci ...... le primary hyperparathyroidism
@en
P2093
P2860
P356
P1476
Cinacalcet reduces serum calci ...... le primary hyperparathyroidism
@en
P2093
Christoph Henzen
Claudio Marcocci
Dolores Shoback
Jacques Orgiazzi
Laureano Fernandez-Cruz
Lulu Ren Sterling
Munro Peacock
Philippe Chanson
Sunfa Cheng
P2860
P304
P356
10.1210/JC.2008-2640
P407
P577
2009-05-26T00:00:00Z